Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Trial)

NCT00135473 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Severe Sepsis
Septic Shock

Interventions

DRUG: 10% Hemohes® (10% Hydroxyethyl starch)
DRUG: Sterofundin® (Ringer lactate solution)
DRUG: Actrapid® (Insulin)

Sponsor

SepNet - Critical Care Trials Group

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]